Iguchi Kimi - Feb 21, 2023 Form 4 Insider Report for Sage Therapeutics, Inc. (SAGE)

Role
CFO & Treasurer
Signature
/s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Kimi Iguchi
Stock symbol
SAGE
Transactions as of
Feb 21, 2023
Transactions value $
$1,360
Form type
4
Date filed
2/23/2023, 05:03 PM
Previous filing
Feb 15, 2023
Next filing
Mar 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SAGE Common Stock Options Exercise $1.02K +750 +1.22% $1.36 62.3K Feb 21, 2023 Direct
transaction SAGE Common Stock Options Exercise $340 +250 +0.4% $1.36 62.6K Feb 23, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SAGE Stock Option (Right to Buy) Options Exercise $0 -750 -13.29% $0.00 4.89K Feb 21, 2023 Common Stock 750 $1.36 Direct F1
transaction SAGE Stock Option (Right to Buy) Options Exercise $0 -250 -5.11% $0.00 4.64K Feb 23, 2023 Common Stock 250 $1.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2011 Stock Option and Incentive Plan. The option vested in full on July 23, 2016.